Sinopharm Group is selling for under 2.58 as of the 5th of January 2025; that is 4.8 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 2.58. Sinopharm Group has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 6th of December 2024 and ending today, the 5th of January 2025. Click here to learn more.
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sinopharm Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sinopharm Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Although Sinopharm Group's alpha and beta are two of the key measurements used to evaluate Sinopharm Group's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Sinopharm Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Idea Breakdown Now
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
When running Sinopharm Group's price analysis, check to measure Sinopharm Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinopharm Group is operating at the current time. Most of Sinopharm Group's value examination focuses on studying past and present price action to predict the probability of Sinopharm Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinopharm Group's price. Additionally, you may evaluate how the addition of Sinopharm Group to your portfolios can decrease your overall portfolio volatility.